Click here to get full coverage on Regeneron (REGN): Revisiting Valuation After Recent Pullback and 90-Day Share Price Surge - Yahoo Finance

Regeneron (REGN): Revisiting Valuation After Recent Pullback and 90-Day Share Price Surge  Yahoo Finance

Regeneron (REGN): Revisiting Valuation After Recent Pullback and 90-Day Share Price Surge - Yahoo Finance

Click here to get full coverage on Regeneron (REGN) Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research

Regeneron (REGN) Just Flashed Golden Cross Signal: Do You Buy?  Zacks Investment Research

Regeneron (REGN) Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research

Click here to get full coverage on Bellevue Group AG Sells 1,779 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Bellevue Group AG Sells 1,779 Shares of Regeneron Pharmaceuticals, Inc. $REGN  MarketBeat

Bellevue Group AG Sells 1,779 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Click here to get full coverage on How Investors May Respond To Regeneron (REGN) Lynozyfic Multiple Myeloma Data And Frontline Oncology Ambitions - simplywall.st

How Investors May Respond To Regeneron (REGN) Lynozyfic Multiple Myeloma Data And Frontline Oncology Ambitions  simplywall.st

How Investors May Respond To Regeneron (REGN) Lynozyfic Multiple Myeloma Data And Frontline Oncology Ambitions - simplywall.st

Click here to get full coverage on Regeneron Pharmaceuticals: Is Wall Street Finally Paying Attention (NASDAQ:REGN) - Seeking Alpha

Regeneron Pharmaceuticals: Is Wall Street Finally Paying Attention (NASDAQ:REGN)  Seeking Alpha

Regeneron Pharmaceuticals: Is Wall Street Finally Paying Attention (NASDAQ:REGN) - Seeking Alpha

Click here to get full coverage on Wells Fargo Maintains Regeneron Pharmaceuticals(REGN.US) With Hold Rating, Raises Target Price to $745 - 富途牛牛

Wells Fargo Maintains Regeneron Pharmaceuticals(REGN.US) With Hold Rating, Raises Target Price to $745  富途牛牛

Wells Fargo Maintains Regeneron Pharmaceuticals(REGN.US) With Hold Rating, Raises Target Price to $745 - 富途牛牛

Click here to get full coverage on Regeneron Pharmaceuticals (REGN) Receives Updated Analyst Ratings from Morgan Stanley | REGN Stock News - GuruFocus

Regeneron Pharmaceuticals (REGN) Receives Updated Analyst Ratings from Morgan Stanley | REGN Stock News  GuruFocus

Regeneron Pharmaceuticals (REGN) Receives Updated Analyst Ratings from Morgan Stanley | REGN Stock News - GuruFocus

Click here to get full coverage on Regeneron (REGN) Gets a Hold from Scotiabank - The Globe and Mail

Regeneron (REGN) Gets a Hold from Scotiabank  The Globe and Mail

Regeneron (REGN) Gets a Hold from Scotiabank - The Globe and Mail

Click here to get full coverage on Regeneron Pharmaceuticals Stock Slides 11% With A 8-Day Losing Spree - Trefis

Regeneron Pharmaceuticals Stock Slides 11% With A 8-Day Losing Spree  Trefis

Regeneron Pharmaceuticals Stock Slides 11% With A 8-Day Losing Spree - Trefis

Click here to get full coverage on Regeneron (REGN) Up 20.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Regeneron (REGN) Up 20.2% Since Last Earnings Report: Can It Continue?  Yahoo Finance

Regeneron (REGN) Up 20.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Click here to get full coverage on Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $768.00 Price Target at Morgan Stanley - MarketBeat

Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $768.00 Price Target at Morgan Stanley  MarketBeat

Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $768.00 Price Target at Morgan Stanley - MarketBeat

Click here to get full coverage on Wells Fargo Raises Price Target for Regeneron (REGN) to $745 | REGN Stock News - GuruFocus

Wells Fargo Raises Price Target for Regeneron (REGN) to $745 | REGN Stock News  GuruFocus

Wells Fargo Raises Price Target for Regeneron (REGN) to $745 | REGN Stock News - GuruFocus

Click here to get full coverage on RBC Capital Sticks to Its Hold Rating for Regeneron (REGN) - The Globe and Mail

RBC Capital Sticks to Its Hold Rating for Regeneron (REGN)  The Globe and Mail

RBC Capital Sticks to Its Hold Rating for Regeneron (REGN) - The Globe and Mail

Click here to get full coverage on Game Creek Capital LP Makes New Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Game Creek Capital LP Makes New Investment in Regeneron Pharmaceuticals, Inc. $REGN  MarketBeat

Game Creek Capital LP Makes New Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Click here to get full coverage on Regeneron’s (REGN) Recovery and Dupixent Strength Support BMO’s Outperform Rating - Yahoo Finance

Regeneron’s (REGN) Recovery and Dupixent Strength Support BMO’s Outperform Rating  Yahoo Finance

Regeneron’s (REGN) Recovery and Dupixent Strength Support BMO’s Outperform Rating - Yahoo Finance

Click here to get full coverage on Regeneron Pharmaceuticals (REGN): Examining Valuation After Recent Share Price Momentum - Yahoo Finance

Regeneron Pharmaceuticals (REGN): Examining Valuation After Recent Share Price Momentum  Yahoo Finance

Regeneron Pharmaceuticals (REGN): Examining Valuation After Recent Share Price Momentum - Yahoo Finance

Click here to get full coverage on The Manufacturers Life Insurance Company Has $199.26 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

The Manufacturers Life Insurance Company Has $199.26 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN  MarketBeat

The Manufacturers Life Insurance Company Has $199.26 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Click here to get full coverage on The Bull Case For Regeneron (REGN) Could Change Following European Approval of Dupixent for CSU Patients - Yahoo Finance

The Bull Case For Regeneron (REGN) Could Change Following European Approval of Dupixent for CSU Patients  Yahoo Finance

The Bull Case For Regeneron (REGN) Could Change Following European Approval of Dupixent for CSU Patients - Yahoo Finance

Click here to get full coverage on REGN Gets EC Nod for Libtayo Label Expansion, FDA Clears Monthly Eylea HD - Yahoo Finance

REGN Gets EC Nod for Libtayo Label Expansion, FDA Clears Monthly Eylea HD  Yahoo Finance

REGN Gets EC Nod for Libtayo Label Expansion, FDA Clears Monthly Eylea HD - Yahoo Finance

Click here to get full coverage on Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory - Yahoo Finance

Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory  Yahoo Finance

Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on REGN & Tessera Collaborate to Develop Gene-Editing Therapy for AATD - Yahoo Finance

REGN & Tessera Collaborate to Develop Gene-Editing Therapy for AATD  Yahoo Finance

REGN & Tessera Collaborate to Develop Gene-Editing Therapy for AATD - Yahoo Finance

Click here to get full coverage on REGN Gains 21.5% in a Month: Time to Buy, Sell or Hold the Stock? - Yahoo Finance

REGN Gains 21.5% in a Month: Time to Buy, Sell or Hold the Stock?  Yahoo Finance

REGN Gains 21.5% in a Month: Time to Buy, Sell or Hold the Stock? - Yahoo Finance

Click here to get full coverage on Intact Investment Management Inc. Grows Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Intact Investment Management Inc. Grows Holdings in Regeneron Pharmaceuticals, Inc. $REGN  MarketBeat

Intact Investment Management Inc. Grows Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Click here to get full coverage on State Street Corp Boosts Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

State Street Corp Boosts Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN  MarketBeat

State Street Corp Boosts Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Click here to get full coverage on Regeneron (REGN): Revisiting Valuation After Recent 16% Share Price Rally - Yahoo Finance

Regeneron (REGN): Revisiting Valuation After Recent 16% Share Price Rally  Yahoo Finance

Regeneron (REGN): Revisiting Valuation After Recent 16% Share Price Rally - Yahoo Finance

Click here to get full coverage on WINTON GROUP Ltd Invests $710,000 in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

WINTON GROUP Ltd Invests $710,000 in Regeneron Pharmaceuticals, Inc. $REGN  MarketBeat

WINTON GROUP Ltd Invests $710,000 in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Click here to get full coverage on Regeneron (REGN): Revisiting Valuation After a Short-Term Pullback and Longer-Term Shareholder Weakness - simplywall.st

Regeneron (REGN): Revisiting Valuation After a Short-Term Pullback and Longer-Term Shareholder Weakness  simplywall.st

Regeneron (REGN): Revisiting Valuation After a Short-Term Pullback and Longer-Term Shareholder Weakness - simplywall.st

Click here to get full coverage on Regeneron Pharmaceuticals (REGN) Stock Outlook: Morgan Stanley Downgrade, Eylea HD Win and Gene‑Editing Push – December 3, 2025Regeneron - ts2.tech

Regeneron Pharmaceuticals (REGN) Stock Outlook: Morgan Stanley Downgrade, Eylea HD Win and Gene‑Editing Push – December 3, 2025Regeneron  ts2.tech

Regeneron Pharmaceuticals (REGN) Stock Outlook: Morgan Stanley Downgrade, Eylea HD Win and Gene‑Editing Push – December 3, 2025Regeneron - ts2.tech

Click here to get full coverage on Ossiam Sells 22,234 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Ossiam Sells 22,234 Shares of Regeneron Pharmaceuticals, Inc. $REGN  MarketBeat

Ossiam Sells 22,234 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Click here to get full coverage on REGN Stock Up on Q3 Earnings Beat, Eylea HD Sales Increase - Yahoo Finance

REGN Stock Up on Q3 Earnings Beat, Eylea HD Sales Increase  Yahoo Finance

REGN Stock Up on Q3 Earnings Beat, Eylea HD Sales Increase - Yahoo Finance

Click here to get full coverage on Regeneron Pharmaceuticals, Inc. (REGN) Prepares for $83M Charge - Yahoo Finance

Regeneron Pharmaceuticals, Inc. (REGN) Prepares for $83M Charge  Yahoo Finance

Regeneron Pharmaceuticals, Inc. (REGN) Prepares for $83M Charge - Yahoo Finance

Click here to get full coverage on Diadema Partners LP Trims Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Diadema Partners LP Trims Stake in Regeneron Pharmaceuticals, Inc. $REGN  MarketBeat

Diadema Partners LP Trims Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Click here to get full coverage on Here’s Why Regeneron Pharmaceuticals (REGN) Fell in Q2 - Yahoo Finance

Here’s Why Regeneron Pharmaceuticals (REGN) Fell in Q2  Yahoo Finance

Here’s Why Regeneron Pharmaceuticals (REGN) Fell in Q2 - Yahoo Finance

Click here to get full coverage on Wells Fargo & Company Issues Positive Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price - MarketBeat

Wells Fargo & Company Issues Positive Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price  MarketBeat

Wells Fargo & Company Issues Positive Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price - MarketBeat

Click here to get full coverage on Stempoint Capital LP Purchases New Shares in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Stempoint Capital LP Purchases New Shares in Regeneron Pharmaceuticals, Inc. $REGN  MarketBeat

Stempoint Capital LP Purchases New Shares in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Click here to get full coverage on Winners And Losers Of Q3: Regeneron (NASDAQ:REGN) Vs The Rest Of The Immuno-Oncology Stocks - Yahoo Finance

Winners And Losers Of Q3: Regeneron (NASDAQ:REGN) Vs The Rest Of The Immuno-Oncology Stocks  Yahoo Finance

Winners And Losers Of Q3: Regeneron (NASDAQ:REGN) Vs The Rest Of The Immuno-Oncology Stocks - Yahoo Finance

Click here to get full coverage on iSAM Funds UK Ltd Acquires New Shares in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

iSAM Funds UK Ltd Acquires New Shares in Regeneron Pharmaceuticals, Inc. $REGN  MarketBeat

iSAM Funds UK Ltd Acquires New Shares in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Click here to get full coverage on Why Are Regeneron (REGN) Shares Soaring Today - Yahoo Finance

Why Are Regeneron (REGN) Shares Soaring Today  Yahoo Finance

Why Are Regeneron (REGN) Shares Soaring Today - Yahoo Finance

Click here to get full coverage on Are Wall Street Analysts Bullish on Regeneron Pharmaceuticals Stock? - Yahoo Finance

Are Wall Street Analysts Bullish on Regeneron Pharmaceuticals Stock?  Yahoo Finance

Are Wall Street Analysts Bullish on Regeneron Pharmaceuticals Stock? - Yahoo Finance

Click here to get full coverage on Natixis Purchases 2,751 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Natixis Purchases 2,751 Shares of Regeneron Pharmaceuticals, Inc. $REGN  MarketBeat

Natixis Purchases 2,751 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Click here to get full coverage on Regeneron (REGN) Margin Compression Reinforces Cautious Community Narratives Heading Into Earnings Season - Yahoo Finance

Regeneron (REGN) Margin Compression Reinforces Cautious Community Narratives Heading Into Earnings Season  Yahoo Finance

Regeneron (REGN) Margin Compression Reinforces Cautious Community Narratives Heading Into Earnings Season - Yahoo Finance

Click here to get full coverage on 3 Low-Volatility Stocks We’re Skeptical Of - The Globe and Mail

3 Low-Volatility Stocks We’re Skeptical Of  The Globe and Mail

3 Low-Volatility Stocks We’re Skeptical Of - The Globe and Mail

Click here to get full coverage on New Analyst Forecast: $REGN Given $700.0 Price Target - Quiver Quantitative

New Analyst Forecast: $REGN Given $700.0 Price Target  Quiver Quantitative

New Analyst Forecast: $REGN Given $700.0 Price Target - Quiver Quantitative

Click here to get full coverage on Why Regeneron (REGN) Stock Is Down Today - Yahoo Finance

Why Regeneron (REGN) Stock Is Down Today  Yahoo Finance

Why Regeneron (REGN) Stock Is Down Today - Yahoo Finance

Click here to get full coverage on Regeneron Pharmaceuticals (REGN) Releases Results From EMPOWER-Lung 3 trial - Yahoo Finance

Regeneron Pharmaceuticals (REGN) Releases Results From EMPOWER-Lung 3 trial  Yahoo Finance

Regeneron Pharmaceuticals (REGN) Releases Results From EMPOWER-Lung 3 trial - Yahoo Finance

Click here to get full coverage on Regeneron (REGN) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance

Regeneron (REGN) Q3 Earnings and Revenues Surpass Estimates  Yahoo Finance

Regeneron (REGN) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance

Click here to get full coverage on Regeneron Pharmaceuticals Inc. (REGN) Reports Positive Results from Several Late-Stage Trials - Yahoo Finance

Regeneron Pharmaceuticals Inc. (REGN) Reports Positive Results from Several Late-Stage Trials  Yahoo Finance

Regeneron Pharmaceuticals Inc. (REGN) Reports Positive Results from Several Late-Stage Trials - Yahoo Finance

Click here to get full coverage on SNY & REGN's Dupixent Gets EU Nod for Chronic Spontaneous Urticaria - Yahoo Finance

SNY & REGN's Dupixent Gets EU Nod for Chronic Spontaneous Urticaria  Yahoo Finance

SNY & REGN's Dupixent Gets EU Nod for Chronic Spontaneous Urticaria - Yahoo Finance

Click here to get full coverage on Exploring Analyst Estimates for Regeneron (REGN) Q3 Earnings, Beyond Revenue and EPS - Yahoo Finance

Exploring Analyst Estimates for Regeneron (REGN) Q3 Earnings, Beyond Revenue and EPS  Yahoo Finance

Exploring Analyst Estimates for Regeneron (REGN) Q3 Earnings, Beyond Revenue and EPS - Yahoo Finance

Click here to get full coverage on BMO Capital Maintains a Buy on Regeneron Pharmaceuticals (REGN) - Yahoo Finance

BMO Capital Maintains a Buy on Regeneron Pharmaceuticals (REGN)  Yahoo Finance

BMO Capital Maintains a Buy on Regeneron Pharmaceuticals (REGN) - Yahoo Finance

Click here to get full coverage on Regeneron Pharmaceuticals (REGN): Is There More Value Ahead After Recent Uptrend? - simplywall.st

Regeneron Pharmaceuticals (REGN): Is There More Value Ahead After Recent Uptrend?  simplywall.st

Regeneron Pharmaceuticals (REGN): Is There More Value Ahead After Recent Uptrend? - simplywall.st

Click here to get full coverage on Why Regeneron (REGN) Shares Are Falling Today - Yahoo Finance

Why Regeneron (REGN) Shares Are Falling Today  Yahoo Finance

Why Regeneron (REGN) Shares Are Falling Today - Yahoo Finance

Click here to get full coverage on Earnings Preview: Regeneron (REGN) Q3 Earnings Expected to Decline - Yahoo Finance

Earnings Preview: Regeneron (REGN) Q3 Earnings Expected to Decline  Yahoo Finance

Earnings Preview: Regeneron (REGN) Q3 Earnings Expected to Decline - Yahoo Finance

Click here to get full coverage on Regeneron Pharmaceuticals, Inc. (REGN) Draws Attention With Rare Disease Breakthrough - Yahoo Finance

Regeneron Pharmaceuticals, Inc. (REGN) Draws Attention With Rare Disease Breakthrough  Yahoo Finance

Regeneron Pharmaceuticals, Inc. (REGN) Draws Attention With Rare Disease Breakthrough - Yahoo Finance

Click here to get full coverage on What analysts say about REGN stock - Equity Performance Review & Free Risk Assessment and Control - earlytimes.in

What analysts say about REGN stock - Equity Performance Review & Free Risk Assessment and Control  earlytimes.in

What analysts say about REGN stock - Equity Performance Review & Free Risk Assessment and Control - earlytimes.in

Click here to get full coverage on Regeneron (REGN): Reevaluating Valuation Following Breakthrough Trial Results and Evkeeza’s FDA Pediatric Approval - Yahoo Finance

Regeneron (REGN): Reevaluating Valuation Following Breakthrough Trial Results and Evkeeza’s FDA Pediatric Approval  Yahoo Finance

Regeneron (REGN): Reevaluating Valuation Following Breakthrough Trial Results and Evkeeza’s FDA Pediatric Approval - Yahoo Finance

Click here to get full coverage on Long Leaf Partners Fund’s Comment on Regeneron (REGN) - Yahoo Finance

Long Leaf Partners Fund’s Comment on Regeneron (REGN)  Yahoo Finance

Long Leaf Partners Fund’s Comment on Regeneron (REGN) - Yahoo Finance

Click here to get full coverage on REGN Gains 21.5% in a Month: Time to Buy, Sell or Hold the Stock? - Finviz

REGN Gains 21.5% in a Month: Time to Buy, Sell or Hold the Stock?  Finviz

REGN Gains 21.5% in a Month: Time to Buy, Sell or Hold the Stock? - Finviz

Click here to get full coverage on Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory - Finviz

Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory  Finviz

Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory - Finviz

Click here to get full coverage on New Analyst Forecast: $REGN Given $850 Price Target - Quiver Quantitative

New Analyst Forecast: $REGN Given $850 Price Target  Quiver Quantitative

New Analyst Forecast: $REGN Given $850 Price Target - Quiver Quantitative

Click here to get full coverage on Regeneron’s (REGN) recovery and Dupixent strength support BMO’s outperform rating - MSN

Regeneron’s (REGN) recovery and Dupixent strength support BMO’s outperform rating  MSN

Regeneron’s (REGN) recovery and Dupixent strength support BMO’s outperform rating - MSN

Click here to get full coverage on How Positive Phase 2 Results for Novel Antibodies at Regeneron Pharmaceuticals (REGN) Has Changed Its Investment Story - Yahoo Finance

How Positive Phase 2 Results for Novel Antibodies at Regeneron Pharmaceuticals (REGN) Has Changed Its Investment Story  Yahoo Finance

How Positive Phase 2 Results for Novel Antibodies at Regeneron Pharmaceuticals (REGN) Has Changed Its Investment Story - Yahoo Finance

Click here to get full coverage on Regeneron (REGN) Showcases Promising Trial Data for Lynozyfic in Multiple Myeloma - GuruFocus

Regeneron (REGN) Showcases Promising Trial Data for Lynozyfic in Multiple Myeloma  GuruFocus

Regeneron (REGN) Showcases Promising Trial Data for Lynozyfic in Multiple Myeloma - GuruFocus

Click here to get full coverage on Will EU Approval of Dupixent for CSU Transform Regeneron Pharmaceuticals' (REGN) Long-Term Growth Narrative? - simplywall.st

Will EU Approval of Dupixent for CSU Transform Regeneron Pharmaceuticals' (REGN) Long-Term Growth Narrative?  simplywall.st

Will EU Approval of Dupixent for CSU Transform Regeneron Pharmaceuticals' (REGN) Long-Term Growth Narrative? - simplywall.st

Click here to get full coverage on Here’s Why You Should Consider Buying Regeneron Pharma (REGN)’s Shares - Yahoo Finance

Here’s Why You Should Consider Buying Regeneron Pharma (REGN)’s Shares  Yahoo Finance

Here’s Why You Should Consider Buying Regeneron Pharma (REGN)’s Shares - Yahoo Finance

Click here to get full coverage on How Does Regeneron Pharmaceuticals Stock Stack Up Against Its Peers? - Trefis

How Does Regeneron Pharmaceuticals Stock Stack Up Against Its Peers?  Trefis

How Does Regeneron Pharmaceuticals Stock Stack Up Against Its Peers? - Trefis

Click here to get full coverage on Scotiabank Reaffirms Their Hold Rating on Regeneron (REGN) - The Globe and Mail

Scotiabank Reaffirms Their Hold Rating on Regeneron (REGN)  The Globe and Mail

REGN

Price Chart

Key Statistics

Technicals

About REGN

Latest News

Regeneron (REGN): Revisiting Valuation After Recent Pullback and 90-Day Share Price Surge - Yahoo Finance

Regeneron (REGN) Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research

Bellevue Group AG Sells 1,779 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Advanced Charts

Top Gainers

Top Losers